Covered recipient · General Payments record
RONALD RAY BURNS
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2023–2024
$225.66
- Reported across 12 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $187.24 | 10 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Acerta Pharma LLC | $50.47 | 3 |
| Astellas Pharma US Inc | $46.08 | 2 |
| PFIZER INC. | $35.75 | 2 |
| Novo Nordisk AS | $24.78 | 1 |
| Esperion Therapeutics, Inc. | $15.46 | 1 |
| Currax Pharmaceuticals LLC | $14.70 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (10)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Astellas Pharma US Inc | $22.93 | 05/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139358297 | CMS |
| Astellas Pharma US Inc | $23.15 | 06/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139365213 | CMS |
| AstraZeneca Pharmaceuticals LP | $19.92 | 02/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105215926 | CMS |
| AstraZeneca Pharmaceuticals LP | $14.99 | 05/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1126679088 | CMS |
| AstraZeneca Pharmaceuticals LP | $15.56 | 07/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104660707 | CMS |
| Currax Pharmaceuticals LLC | $14.70 | 01/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1089515088 | CMS |
| Esperion Therapeutics, Inc. | $15.46 | 02/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1129429580 | CMS |
| Novo Nordisk Inc | $24.78 | 08/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097061051 | CMS |
| PFIZER INC. | $21.46 | 03/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1132033913 | CMS |
| PFIZER INC. | $14.29 | 09/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1130883601 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2023, 2024
- Source files
- Dataset page · Bulk file · PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.